- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00632320
Continuous Positive Airway Pressure and Oxygen Concentration on Measurement of Rapid Shallow Breathing Index
March 7, 2008 updated by: Taipei Veterans General Hospital, Taiwan
Effect of Continuous Positive Airway Pressure and Oxygen Concentration on Measurement of Rapid Shallow Breathing Index
To compare the rapid shallow breathing index (RSBI) values, the incidence of adverse reactions, and the predictive accuracy measured under 5 different ventilator strategies in the same patient group.
Study Overview
Status
Completed
Conditions
Detailed Description
98 ready for weaning patients were included and divided into success (n=71) and failure (n=27) groups based upon their weaning outcome.
Before weaning, the RSBI values were determined under the patients disconnecting from the ventilator (RA-no ventilator) and still connecting to the ventilator with 4 different settings (fraction of inspired oxygen (FiO2) 21 or 40% combined with continuous positive airway pressure (CPAP) 0 or 5 cm H2O).
The patients were extubated after completing the weaning trials.
Successful weaning was defined as patients free from the ventilator for over 48 hours.
Study Type
Observational
Enrollment (Actual)
98
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 112
- Respiratory Therapy Intensive Care Unit, Taipei Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
respiratory therapy intensive Care unit in a medical center
Description
Inclusion Criteria:
- intubated medical patients with mechanically ventilated more than 48 hours
- clinically ready for weaning
- Glasgow coma scales were at least 8
- their ventilator settings were: assist-controlled, pressure support (PS)or synchronized intermittent mandatory ventilation plus PS mode, FiO2 40% or less, positive end-expiratory pressure 5 cm H2O or less, and sensitivity setting on 1 L/min. Their arterial blood gases results were acceptable
Exclusion Criteria:
- having ongoing lung or neuromuscular disease and signs of increased intracranial pressure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
S, 1, A
group (success or failure), case number, measurement method
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The patients connecting or disconnecting to the ventilators affected the RSBI values but not their predictive accuracies.
Time Frame: Before the patient processing weaning trials
|
Before the patient processing weaning trials
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in FiO2 and CPAP settings have no effect on RSBI values but ventilator methods with FiO2 21% have higher incidence of adverse reactions.
Time Frame: Before the patient processing weaning trials
|
Before the patient processing weaning trials
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mauo-Ying Bien, PhD, School of Respiratory Therapy, Taipei Medical University, Taipei, Taiwan, ROC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2004
Primary Completion (Actual)
December 1, 2004
Study Completion (Actual)
August 1, 2005
Study Registration Dates
First Submitted
March 2, 2008
First Submitted That Met QC Criteria
March 7, 2008
First Posted (Estimate)
March 10, 2008
Study Record Updates
Last Update Posted (Estimate)
March 10, 2008
Last Update Submitted That Met QC Criteria
March 7, 2008
Last Verified
March 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- VGHIRB No.:93-09-02A
- Grant 94CM-TMU-13
- Grant NSC94-2314-B-038-039
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.